Oscar Health (NYSE:OSCR) Given New $11.00 Price Target at Wells Fargo & Company

Oscar Health (NYSE:OSCR) had its price target lowered by Wells Fargo & Company from $14.00 to $11.00 in a report published on Thursday,Benzinga reports. The firm currently has an underweight rating on the stock.

Several other brokerages have also issued reports on OSCR. Wall Street Zen lowered shares of Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, August 9th. Barclays upped their target price on shares of Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research note on Monday. Baird R W lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, July 25th. Piper Sandler dropped their price objective on Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a research report on Thursday, August 14th. Finally, UBS Group lifted their price objective on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a report on Friday, November 7th. Six analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $13.14.

Oscar Health Price Performance

Oscar Health stock traded down $0.09 during mid-day trading on Thursday, reaching $13.86. The company’s stock had a trading volume of 12,599,652 shares, compared to its average volume of 15,794,138. The firm’s fifty day moving average price is $18.95 and its two-hundred day moving average price is $16.85. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. Oscar Health has a 12-month low of $11.20 and a 12-month high of $23.80.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business’s quarterly revenue was up 23.2% on a year-over-year basis. During the same quarter last year, the company posted ($0.22) EPS. Oscar Health has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Mario Schlosser sold 395,000 shares of the firm’s stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider directly owned 501,148 shares in the company, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 24.39% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Large investors have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. raised its position in shares of Oscar Health by 23.8% in the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company’s stock worth $3,749,000 after acquiring an additional 54,938 shares in the last quarter. Nuveen LLC bought a new position in Oscar Health in the first quarter worth about $29,684,000. NewEdge Advisors LLC lifted its position in shares of Oscar Health by 89.7% during the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company’s stock valued at $2,465,000 after buying an additional 88,946 shares during the last quarter. Matauro LLC bought a new stake in shares of Oscar Health in the 2nd quarter valued at about $1,508,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its stake in Oscar Health by 19.0% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company’s stock valued at $6,581,000 after acquiring an additional 79,979 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.